Allegiant Private Advisors’s Pfizer PFE Stock Holding History

Allegiant Private Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$497K	Buy	12,693 +414	+3%	+$16.1K	0.08%	106
2021 Q1	$445K	Buy	12,279 +2,959	+32%	+$105K	0.08%	105
2020 Q4	$343K	Buy	+9,320	New	+$342K	0.07%	108

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allegiant Private Advisors's PFE Position: Q2 2021 in Review

Allegiant Private Advisors increased its Pfizer (PFE) stake by 3.4% in Q2 2021, buying an estimated $16.1K and bringing the position to 12,693 shares worth $497K. The position accounts for 0.08% of the portfolio, ranked #106.

Allegiant Private Advisors first reported a position in PFE in Q4 2020 and has held it in 3 quarters since. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Allegiant Private Advisors held 12,693 shares of Pfizer worth $497K as of Q2 2021.
Allegiant Private Advisors bought 414 Pfizer shares in Q2 2021, an estimated $16.1K.
Pfizer made up 0.08% of Allegiant Private Advisors's portfolio in Q2 2021, its #106 holding.
Allegiant Private Advisors first reported a position in Pfizer in Q4 2020 and has held it in 3 quarters since.
2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.